AIL
BHVN

AGF Investments LLC’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

AGF Investments LLC’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.75M Buy
11,560
+4,909
+74% +$728K 0.16% 35
2022
Q2 		$969K Buy
6,651
+360
+6% +$46K 0.09% 80
2022
Q1 		$746K Sell
6,291
-694
-10% -$86.6K 0.06% 219
2021
Q4 		$963K Buy
+6,985
New +$888K 0.08% 54

Other funds holding BHVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AGF Investments LLC's BHVN Position: Q3 2022 in Review

AGF Investments LLC increased its Biohaven Pharmaceutical Holding Company Ltd. (BHVN) stake by 74% in Q3 2022, buying an estimated $728K and bringing the position to 11,560 shares worth $1.75M. The position accounts for 0.16% of the portfolio, ranked #35.

AGF Investments LLC first reported a position in BHVN in Q4 2021 and has held it in 4 quarters since. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

  • AGF Investments LLC held 11,560 shares of Biohaven Pharmaceutical Holding Company Ltd. worth $1.75M as of Q3 2022.
  • AGF Investments LLC bought 4,909 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $728K.
  • Biohaven Pharmaceutical Holding Company Ltd. made up 0.16% of AGF Investments LLC's portfolio in Q3 2022, its #35 holding.
  • AGF Investments LLC first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2021 and has held it in 4 quarters since.
  • 240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on AGF Investments LLC's 13F filing for Q3 2022, filed 10 Nov 2022.